author-photo

M. Valladares

42

Papers

623

Citations

Citation Trend

Filter By

Papers (33) Sort By

Journal Conference Others

Phase II study of high-sensitivity genotyping of KRAS, NRAS, BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (13)
Author Correction: Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer

2019 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (1)
Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer

2019 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (5)
PIER trial: Neoadjuvant therapy with panitumumab (P) and mFOLFOX-6 in an enriched population of patients with T3 rectal adenocarcinoma of the middle third with clear mesorectal fascia.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Psychological aspects associated with eating behavior and obesity in university Chilean students

2018 Clinical Nutrition
Show All
- Source
- Cite
- Save
Citations (0)
Cost-effectiveness analysis in the Spanish setting of the PEAK trial of panitumumab plus mFOLFOX6 compared with bevacizumab plus mFOLFOX6 for first-line treatment of patients with wild-type RAS metastatic colorectal cancer

2017 Journal of Medical Economics
Show All
- Source
- Cite
- Save
Citations (7)
Pharmacogenetic analysis of TS and UGT1A polymorphisms predictive for response and toxicity in Spanish patients with advanced colorectal cancer treated with first-line irinotecan and 5-fluorouracil

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Activity of aflibercept (Afli) in combination with FOLFIRI (F) for patients with metastatic colorectal cancer (mCRC) in a real-life setting in Spain: Final results of the retrospective study Named Patient Program.

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Comparison of three molecular methods to detect mutations in KRAS, NRAS, BRAF and PIK3CA in metastatic colorectal cancer (mCRC).

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Effect of pharmacogenetic-based selection of first-line chemotherapy on response rate and R0 surgery in metastatic CRC patients.

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)